Cargando…

Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation

Body mass index (BMI) influences the prognosis of patients with non-small cell lung cancer (NSCLC), including both early-stage and late-stage NSCLC patients that are undergoing chemotherapies. However, earlier research on the relationship between BMI and survival in patients taking epidermal growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Mu, Lai, Chien-Hao, Lin, Chiung-Yu, Tsai, Yi-Hsuan, Chang, Ya-Chun, Chen, Hung-Chen, Tseng, Chia-Cheng, Chang, Huang-Chih, Huang, Kuo-Tung, Chen, Yung-Che, Fang, Wen-Feng, Wang, Chin-Chou, Chao, Tung-Ying, Lin, Meng-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622618/ https://www.ncbi.nlm.nih.gov/pubmed/34836017 http://dx.doi.org/10.3390/nu13113761

Ejemplares similares

Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence
por: Chang, Huang‐Chih, et al.
Publicado: (2023)

Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs
por: Chang, Huang‐Chih, et al.
Publicado: (2023)

The Influence of Obesity on Different Genders in Patients with Obstructive Sleep Apnea
por: Huang, Kuo-Tung, et al.
Publicado: (2014)

Insufficient Nutrition and Mortality Risk in Septic Patients Admitted to ICU with a Focus on Immune Dysfunction
por: Hung, Kai-Yin, et al.
Publicado: (2019)

Impact of Body Mass Index on the Survival of Patients with Sepsis with Different Modified NUTRIC Scores
por: Tsai, Yi-Hsuan, et al.
Publicado: (2021)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
por: Chang, Ya-Chun, et al.
Publicado: (2022)

E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis
por: Chang, Yu-Ping, et al.
Publicado: (2023)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Dynamic monitoring of kidney injury status over 3 days in the intensive care unit as a sepsis phenotype associated with hospital mortality and hyperinflammation
por: Lin, Chiung-Yu, et al.
Publicado: (2022)

Application of a 72 h National Early Warning Score and Incorporation with Sequential Organ Failure Assessment for Predicting Sepsis Outcomes and Risk Stratification in an Intensive Care Unit: A Derivation and Validation Cohort Study
por: Hsu, Chih-Yi, et al.
Publicado: (2021)

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms
por: Chen, Yung-Che, et al.
Publicado: (2022)

Risk factors and associated outcomes of ventilator-associated events developed in 28 days among sepsis patients admitted to intensive care unit
por: Fang, Wen-Feng, et al.
Publicado: (2020)

Comparing survival and treatment response of patients with acquired T790M mutation second‐line osimertinib versus sequential treatment of chemotherapy followed by osimertinib: A real‐world study
por: Wang, Chin‐Chou, et al.
Publicado: (2021)

Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2016)

Aberrant DNA methylation of the toll-like receptors 2 and 6 genes in patients with obstructive sleep apnea
por: Huang, Kuo-Tung, et al.
Publicado: (2020)

Ventilator Dependence Risk Score for the Prediction of Prolonged Mechanical Ventilation in Patients Who Survive Sepsis/Septic Shock with Respiratory Failure
por: Chang, Ya-Chun, et al.
Publicado: (2018)

A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases
por: Chen, Yu-Mu, et al.
Publicado: (2016)

Incorporation of dynamic segmented neutrophil-to-monocyte ratio with leukocyte count for sepsis risk stratification
por: Fang, Wen-Feng, et al.
Publicado: (2019)

Effect of do-not-resuscitate orders on patients with sepsis in the medical intensive care unit: a retrospective, observational and propensity score-matched study in a tertiary referral hospital in Taiwan
por: Chang, Ya-Chun, et al.
Publicado: (2019)

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2016)

Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease
por: Chen, Yung-Che, et al.
Publicado: (2018)

Blood Absolute T Cell Counts may Predict 2-Month Treatment Response in Patients with Pulmonary Tuberculosis
por: Chen, Yung-Che, et al.
Publicado: (2010)

Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression
por: Fang, Wen-Feng, et al.
Publicado: (2018)

Association of baseline parameters with year 0 and year 1 acute exacerbations in male patients with chronic obstructive pulmonary disease
por: Chang, Yu-Ping, et al.
Publicado: (2022)

Levels of Circulating Microparticles in Lung Cancer Patients and Possible Prognostic Value
por: Tseng, Chia-Cheng, et al.
Publicado: (2013)

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023)

Factors Predicting Ventilator Dependence in Patients with Ventilator-Associated Pneumonia
por: Tseng, Chia-Cheng, et al.
Publicado: (2012)

The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer
por: Chang, Yu-Ping, et al.
Publicado: (2017)

Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
por: Wang, Chin-Chou, et al.
Publicado: (2017)

Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea
por: Chen, Yung-Che, et al.
Publicado: (2017)

5-Lipoxygenase Activating Protein (FLAP) Dependent Leukotriene Biosynthesis Inhibition (MK591) Attenuates Lipid A Endotoxin-Induced Inflammation
por: Fang, Wen-Feng, et al.
Publicado: (2014)

Immune profiles and clinical outcomes between sepsis patients with or without active cancer requiring admission to intensive care units
por: Fang, Wen-Feng, et al.
Publicado: (2017)

Comprehensive analysis of PD‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue
por: Wang, Chin‐Chou, et al.
Publicado: (2021)

Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients
por: Lin, Chiung-Yu, et al.
Publicado: (2016)

A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy
por: Wang, Chin-Chou, et al.
Publicado: (2021)

EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
por: Tseng, Chien-Hua, et al.
Publicado: (2017)

Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients
por: Chen, Yung-Che, et al.
Publicado: (2019)

Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
por: Tseng, Jeng-Sen, et al.
Publicado: (2014)

Development and validation of immune dysfunction score to predict 28-day mortality of sepsis patients
por: Fang, Wen-Feng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u0hqd8jvjmstmon4ohcifnaadm